Artificial Organs: Global Markets
Report Scope:
This report is a comprehensive study of the global artificial organs market. It describes the artificial organs market, segmented by product type and region. Based on product type, the market is segmented into artificial hearts, artificial kidneys, artificial lungs, artificial pancreases, and cochlear implants. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific, and the Rest of the World (RoW).
This report examines the factors driving growth in the artificial organ market, and it reviews major players, established companies, and new entrants.
This report, however, does not cover artificial limbs, artificial eyes, artificial intestines, artificial skin, or artificial blood vessels.
Report Includes:
28 data tables and 14 additional tables
An overview of the global artificial organs market
Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
Discussion about the benefits of using artificial organs over traditional organs in transplantation surgeries, and increase in development of new types of artificial organs as driving factors to the market
Identification of challenges and discussion on how to overcome from those to reach its commercialization potential
Insights into R&D investments, government growth-promoting policies, rules, and regulations
Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
Detailed company profiles of major players in the market, including Abbott, Getinge AB, LivaNova, Nipro Corp. and Sonova
Companies Mentioned
ABBOTT
ABIOMED
B. Braun Se
BAXTER INTERNATIONAL INC.
COCHLEAR LTD.
F. HOFFMANN-LA ROCHE LTD.
FRESENIUS MEDICAL CARE AG & CO. KGAA
GETINGE AB
INSULET CORP.
LIVANOVA PLC
MED-EL MEDICAL ELECTRONICS
MEDTRONIC
NIPRO CORP.
SONOVA
TANDEM DIABETES CARE, INC.
TERUMO CORP.
YPSOMED AG
Table of Contents Chapter 1 Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Methodology Information Sources Primary Research Secondary Research Geographic Breakdown Chapter 2 Summary and Highlights Market Outlook Highlights of the Artificial Organs Market Chapter 3 Market Overview and Definitions Overview Artificial Organs Chapter 4 Market Trends Market Drivers Aging Population Diabetic Cases by Countries Chronic Kidney Disease Cases by Countries Penetration of Artificial Organs in Emerging Markets Market Opportunity Market Restraints Chapter 5 Market Breakdown by Product Type Introduction Artificial Heart Artificial Kidney Artificial Lung Artificial Pancreas Cochlear Implant Chapter 6 COVID-19 Impact Analysis Introduction COVID-19 Impact on the Medical Devices and Pharmaceutical Industries Decline/Delay in Elective Procedures Impact of COVID-19 on Medical Device and Pharmaceutical Product Segments COVID-19 Impact on Artificial Organs Markets Chapter 7 Market Breakdown by Region Market Overview and Discussion North America U.S. Canada Mexico Latin America Brazil Argentina Chile Europe Germany France U.K. Spain Italy Rest of Europe Asia-Pacific China India Japan Rest of Asia-Pacific Rest of the World Chapter 8 Competitive Landscape Industry Scenario Company Shares Chapter 9 Emerging/Upcoming Technologies Key/Emerging Technologies/Trends in the Market Tissue Engineering and Regenerative Medicine Organ-on-a-Chip Bio-fabrication and 3D Bioprinting Biomaterials and Biocompatible Materials Immunomodulation and Immunotolerance Strategies Neural Interfaces and Brain-Machine Interfaces Gene Editing and Gene Therapy Chapter 10 M&A and Fundings Outlook M&A Analysis SynCardia System's Acquisition by Versa Capital Management Abiomed's Acquisition of Berlin Heart LivaNova's Acquisition of TandemLife Fresenius Medical Care's Acquisition of NxStage Medical B. Braun's Acquisition of NxStage Medical's Bloodlines Business LivaNova's Acquisition of TandemLife Cantel Medical's Acquisition of hemodialysis business from Gambro Eli Lilly's Acquisition of Protomer Technologies Johnson & Johnson Acquisition of Abiomed Inc. Chapter 11 Sustainability in Artificial Organs Market: An ESG Perspective Introduction Environmental Factors Social Factors Governance Factors Artificial Organs Market: ESG Performance Analysis, by Company Conclusion Chapter 12 Patent Analysis Patent Analysis by Manufacturer Chapter 13 Pipeline Analysis Clinical Trials Scenario Chapter 14 Company Profiles ABIOMED ABBOTT BAXTER INTERNATIONAL INC. B. BRAUN SE COCHLEAR LTD. FRESENIUS MEDICAL CARE AG & CO. KGAA F. HOFFMANN-LA ROCHE AG GETINGE AB INSULET CORP. LIVANOVA PLC MEDTRONIC MED-EL MEDICAL ELECTRONICS NIPRO CORP. SONOVA TERUMO CORP. TANDEM DIABETES CARE, INC. YPSOMED AG
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook